Donghang Xu

1.4k total citations
54 papers, 995 citations indexed

About

Donghang Xu is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Donghang Xu has authored 54 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Biomaterials and 10 papers in Biomedical Engineering. Recurrent topics in Donghang Xu's work include Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (9 papers) and Nanoplatforms for cancer theranostics (8 papers). Donghang Xu is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (9 papers) and Nanoplatforms for cancer theranostics (8 papers). Donghang Xu collaborates with scholars based in China, United States and Japan. Donghang Xu's co-authors include Jianqing Gao, Min Han, Xiaohui Fan, Xin Shao, Ni Ai, Jie Liao, Ning Lv, Rui Xue, Wenquan Liang and Lingling Huang and has published in prestigious journals such as Nature Communications, ACS Nano and Chemical Engineering Journal.

In The Last Decade

Donghang Xu

49 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donghang Xu China 17 449 226 216 130 124 54 995
Urarika Luesakul Thailand 9 378 0.8× 198 0.9× 188 0.9× 160 1.2× 64 0.5× 9 940
Chang Su China 22 536 1.2× 225 1.0× 424 2.0× 132 1.0× 155 1.3× 43 1.2k
Zeting Yuan China 18 411 0.9× 275 1.2× 238 1.1× 194 1.5× 86 0.7× 31 1.0k
Emmanuel O. Akala United States 11 355 0.8× 165 0.7× 175 0.8× 105 0.8× 102 0.8× 26 920
Juliette Vergnaud France 22 676 1.5× 312 1.4× 364 1.7× 88 0.7× 116 0.9× 46 1.3k
Jacinta O. Pinho Portugal 14 359 0.8× 249 1.1× 226 1.0× 83 0.6× 61 0.5× 27 976
Florence Gattacceca France 15 326 0.7× 172 0.8× 235 1.1× 67 0.5× 93 0.8× 33 809
Wenhui Tao China 13 301 0.7× 255 1.1× 223 1.0× 84 0.6× 63 0.5× 24 696
Kaushik Kuche India 19 424 0.9× 267 1.2× 389 1.8× 71 0.5× 182 1.5× 41 1.1k

Countries citing papers authored by Donghang Xu

Since Specialization
Citations

This map shows the geographic impact of Donghang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghang Xu more than expected).

Fields of papers citing papers by Donghang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghang Xu. The network helps show where Donghang Xu may publish in the future.

Co-authorship network of co-authors of Donghang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Donghang Xu. A scholar is included among the top collaborators of Donghang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donghang Xu. Donghang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Nan, Mingjian Zhu, Jiahe Wu, et al.. (2025). Dual-targeting pluripotential biomimetic nanovehicle modulates tumor immune microenvironment for potentiated cancer chemoimmunotherapy. Chemical Engineering Journal. 523. 167894–167894.
2.
Chen, Xiaotong, et al.. (2025). Meta-analysis of yoga-based mind-body interventions in the management of inflammatory bowel disease. Complementary Therapies in Medicine. 95. 103287–103287.
3.
Zhang, Mei, et al.. (2025). Electrochemiluminescent/colorimetric monitoring 25(OH)D3 based on HOFs-g-C3N4-CeO2 functional composite. Microchimica Acta. 192(5). 323–323. 1 indexed citations
4.
Liu, Songliang, Donghang Xu, Cong Zhang, et al.. (2025). Ultrafine PdMo alloy nanowires mitigate excessive oxygen adsorption to enhance oxygen reduction in Zn-air batteries. Journal of Colloid and Interface Science. 699(Pt 2). 138273–138273.
5.
Liu, Hui, Lu Li, Juanjuan Zheng, et al.. (2024). Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere. Journal of Controlled Release. 371. 484–497. 9 indexed citations
6.
Lu, Yan, et al.. (2024). Combining AI and traditional screening for discovery of a potent ROCK2 inhibitor against lymphoma. Journal of Molecular Structure. 1303. 137394–137394.
7.
8.
Ye, Chenyi, Yu Guo, Lu Yan, et al.. (2024). Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation. Archiv der Pharmazie. 357(9). e2400066–e2400066. 2 indexed citations
9.
Huang, Ting, Hao Sun, Ruyi Lin, et al.. (2023). High Targeting Specificity toward Pulmonary Inflammation Using Mesenchymal Stem Cell‐Hybrid Nanovehicle for an Efficient Inflammation Intervention. Advanced Healthcare Materials. 12(23). e2300376–e2300376. 11 indexed citations
10.
Huang, Ting, Ruyi Lin, Xiaoyan Lu, et al.. (2023). Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis. Nature Communications. 14(1). 5781–5781. 61 indexed citations
11.
Wang, Tiantian, Haiqing Zhong, Yi Zhou, et al.. (2022). Blocking CD47 with restructured peptide nanoparticles for motivating phagocytosis to inhibit tumor progression. Biomaterials Science. 10(15). 4324–4334. 3 indexed citations
12.
Lin, Mengting, Yiying Lu, Tiantian Wang, et al.. (2022). Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats. Polymers. 14(11). 2181–2181. 13 indexed citations
13.
Wang, Ruxuan, Qiong Bian, Yihua Xu, Donghang Xu, & Jian-Qing Gao. (2021). Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugs. International Journal of Pharmaceutics. 602. 120598–120598. 30 indexed citations
14.
Xu, Donghang, et al.. (2021). Uniform iron oxide nanoparticles reduce the required amount of polyethylenimine in the gene delivery to mesenchymal stem cells. Nanotechnology. 33(12). 125101–125101. 3 indexed citations
15.
Zhang, Tianyuan, Ting Huang, Ruyi Lin, et al.. (2021). Iron Oxide Nanoparticles Promote Cx43-Overexpression of Mesenchymal Stem Cells for Efficient Suicide Gene Therapy during Glioma Treatment. Theranostics. 11(17). 8254–8269. 28 indexed citations
17.
Shao, Xin, Ning Lv, Jie Liao, et al.. (2019). Copy number variation is highly correlated with differential gene expression: a pan-cancer study. BMC Medical Genetics. 20(1). 175–175. 174 indexed citations
18.
Shao, Xin, Ni Ai, Donghang Xu, & Xiaohui Fan. (2016). Exploring the interaction between Salvia miltiorrhiza and human serum albumin: Insights from herb–drug interaction reports, computational analysis and experimental studies. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 161. 1–7. 22 indexed citations
19.
Gao, Jianqing, Yasuhiro Tsuda, Min Han, et al.. (2008). NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy. Cancer Immunology Immunotherapy. 58(2). 291–299. 17 indexed citations
20.
Xu, Donghang, Honggang Lou, Hong Yuan, et al.. (2007). Quantitative determination of domperidone in human plasma by ultraperformance liquid chromatography with electrospray ionization tandem mass spectrometry. Biomedical Chromatography. 22(4). 433–440. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026